Two siblings suffering from Angelman Syndrome with a novel c.1146T>G mutation in UBE3A: A case report

• Published in: Biomedical reports 2022-06, Vol.16 (6), p.48, Article 48
• Main Authors: Liu, Can, Liu, Rui-Hua, Sun, Guang-Fei, Yang, Lin, Zheng, Qin-Liang, Wei, Shan-Ying, Kong, Qing-Xia, Li, Qiu-Bo
• Format: Article
• Language: English
• Subjects: Abnormalities; Amino acids; Angelman's syndrome; Asparagine; Bioinformatics; Case Report; Case reports; Children & youth; Chromosome 15; Consent; Convulsions & seizures; Copy number; Disease; DNA methylation; EEG; Electroencephalography; Epilepsy; Families & family life; Genes; Genetic disorders; Health services; Hospitals; Intellectual disabilities; Lysine; Medical treatment; Metabolism; Missense mutation; Mutation; N gene; Neurodevelopmental disorders; Neuroimaging; Parents & parenting; Pediatrics; Polypeptides; Proteins; Seizures; Ubiquitin; Ubiquitin-protein ligase
• ISSN: 2049-9434; 2049-9442
• DOI: 10.3892/br.2022.1531

Angelman syndrome (AS) is an autosomal dominant neurodevelopmental genetic disease with maternal imprint, which is associated with the presence of the abnormal chromosome 15q11-q13, and the loss of maternal specific expression of ubiquitin-protein ligase E3A (UBE3A). The expression levels of UBE3A depend on the parental origin and exhibit tissue specificity. In normal brain tissues, the maternal UBE3A gene is actively expressed, whereas the paternal UBE3A gene is not. In total, ~85% of pediatric patients with AS present with epilepsy within their 3rd year of life. This condition is usually difficult to control with medical treatment. An 8-year-old female visited the Affiliated Hospital of Jining Medical University due to frequent epilepsy. Her clinical manifestations included specific facial features, moderate mental retardation and frequent seizures. It was interesting to note that her 15-year-old sister exhibited similar clinical manifestations to those of AS. The results of the electroencephalogram and the imaging examinations were also in line with the characteristics of AS. In order to further clarify the diagnosis, all the suspected genes in her sister and in their parents were sequenced. The multiplex ligation-dependent probe amplification project of the Angel/chubby and copy number variation (CNV) sequencing were assessed concomitantly to identify the pathogenic genes responsible for the development of AS. The latter occurs due to the missense mutation c.1146T>G, which results in asparagine replacement by lysine at position 382 (p.Asn382Lys) in exon 7. This amino acid change affects the normal expression of UBE3A; the mutation is a novel mutation, which, to the best of our knowledge, has not been previously reported. Relevant large fragments of mutations and methylation abnormalities were not found in the associated genes. The data further revealed absence of 25-bp repeat mutations at the shear mutation site of exon 1 of the small nuclear ribonucleoprotein polypeptide N gene in the subjects examined. No suspected CNV was found following analysis.